-
EP2864359
European procedure
Extract from the Register of European Patents
EP About this file: EP2864359
| EP2864359 - ANTI-CD26 ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.02.2020 Database last updated on 03.05.2025 | |
| Former | The patent has been granted Status updated on 22.03.2019 | ||
| Former | Grant of patent is intended Status updated on 21.01.2019 | ||
| Former | Examination is in progress Status updated on 06.06.2017 | Most recent event Tooltip | 28.02.2020 | No opposition filed within time limit | published on 01.04.2020 [2020/14] | Applicant(s) | For all designated states ADIENNE S.A. Via Zurigo, 46 6900 Lugano / CH | [2015/18] | Inventor(s) | 01 /
DI NARO, Antonio Francesco Via San Bartolomee CH-6922 Morcote / CH | [2015/18] | Representative(s) | Hoefer & Partner Patentanwälte mbB Pilgersheimer Straße 20 81543 München / DE | [2019/17] |
| Former [2015/18] | Andrae | Westendorp Patentanwälte Partnerschaft Uhlandstraße 2 80336 München / DE | Application number, filing date | 14705767.3 | 19.02.2014 | [2019/17] | WO2014EP53243 | Priority number, date | EP20130425029 | 19.02.2013 Original published format: EP 13425029 | [2015/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014128168 | Date: | 28.08.2014 | Language: | EN | [2014/35] | Type: | A1 Application with search report | No.: | EP2864359 | Date: | 29.04.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.08.2014 takes the place of the publication of the European patent application. | [2015/18] | Type: | B1 Patent specification | No.: | EP2864359 | Date: | 24.04.2019 | Language: | EN | [2019/17] | Search report(s) | International search report - published on: | EP | 28.08.2014 | Classification | IPC: | C07K16/28, A61P37/06 | [2015/18] | CPC: |
C07K16/2896 (EP,KR,RU,US);
A61K39/3955 (RU,US);
A61P37/06 (EP,US);
A61P7/06 (EP,US);
C07K16/40 (RU,US);
A61K2039/505 (EP,KR,US);
A61K2039/545 (EP,KR,US);
C07K2317/24 (US);
C07K2317/33 (EP,KR,US);
C07K2317/34 (US);
C07K2317/565 (US);
C07K2317/76 (US);
C07K2317/92 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/18] | Extension states | BA | 04.02.2015 | ME | 04.02.2015 | Title | German: | ANTI-CD26-ANTIKÖRPER UND VERWENDUNGEN DAVON | [2015/18] | English: | ANTI-CD26 ANTIBODIES AND USES THEREOF | [2015/18] | French: | ANTICORPS ANTI-CD26 ET LEURS UTILISATIONS | [2019/04] |
| Former [2015/18] | ANTICORPS ANTI-CD-26 ET APPLICATIONS ASSOCIÉES | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 26.01.2015 | National basic fee paid | 26.01.2015 | Designation fee(s) paid | 26.01.2015 | Examination fee paid | Examination procedure | 26.01.2015 | Examination requested [2015/18] | 09.10.2015 | Amendment by applicant (claims and/or description) | 24.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 24.10.2016 | Reply to a communication from the examining division | 26.05.2017 | Despatch of a communication from the examining division (Time limit: M06) | 04.12.2017 | Reply to a communication from the examining division | 14.12.2018 | Cancellation of oral proceeding that was planned for 17.12.2018 | 17.12.2018 | Date of oral proceedings (cancelled) | 22.01.2019 | Communication of intention to grant the patent | 12.03.2019 | Fee for grant paid | 12.03.2019 | Fee for publishing/printing paid | 12.03.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19170670.4 / EP3536711 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.06.2016 | Opposition(s) | 27.01.2020 | No opposition filed within time limit [2020/14] | Fees paid | Renewal fee | 29.01.2016 | Renewal fee patent year 03 | 24.11.2016 | Renewal fee patent year 04 | 26.02.2018 | Renewal fee patent year 05 | 28.02.2019 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]EP1179542 (EUROGENETICS NV [BE], et al); | [Y]WO02092127 (UNIV TEXAS [US], et al); | [XDY]WO2007014169 (Y S THERAPEUTICS INC [US], et al); | [Y]US2007060528 (CHRISTOPHER RONALD J [US], et al); | by applicant | US4036945 | US4331647 | US4683195 | US4704692 | US4946778 | EP0404097 | WO9311161 | US5229275 | US5545806 | US5545807 | US5567610 | US5633425 | US5661016 | EP1241179 | WO2007014169 | US2010196266 | US7863239 | US7972993 | US7982013 |